Viewing Study NCT03655002


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2026-01-07 @ 1:59 PM
Study NCT ID: NCT03655002
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-17
First Post: 2018-08-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module